Detecting Zika – Early and Accurately

Friday, August 19, 2016 11:00 am EDT



David Pacitti, President of Siemens Medical Solutions USA, Inc. and Head of Siemens Healthineers North America Regional Organization

Recently, we shared news about next47, a new, independent unit within Siemens dedicated to pursuing disruptive ideas and new technologies. We’re taking our U.S. efforts to California’s Silicon Valley – in the heart of America’s startup culture – where Siemens already has a record of innovation.

In fact, in the city of Berkeley, where our new next47 office will be, Siemens Healthineers’ Molecular Diagnostics team is already advancing innovation in the world of genetic testing – including the fight against the Zika virus. Recently, our new molecular testing kit for the Zika virus was granted an Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA).

Zika has been linked to a number of harmful impacts – even birth defects such as microcephaly. And while there’s been a flood of stories, tweets, and explainers about the virus recently, something that stands out to us – and has been widely reported in the media – is this:

Four out of five people who have Zika don’t know it.*

We invested in R&D to innovate Zika detection technology, supporting physicians in their efforts to diagnose patients quickly and accurately. Molecular tests can be an earlier indicator of Zika virus infection than tests for anti-Zika antibodies. And we see this as a step forward in our efforts to stop the spread of the disease.

Read our full press release to learn more.

*Frieden, Tom.  Centers for Disease Control and Prevention. “Transcript for CDC Telebriefing: Zika.”  February 5, 2016.


All Other Multimedia: 
Preview image